
Graniarc 1mg Injection
Marketer
Arco Lifesciences
Salt Composition
Granisetron (1mg)
Overview Graniarc 1mg Injection
Ondansetron 1mg injection effectively manages nausea and vomiting stemming from surgery, chemotherapy, or radiation therapy. This antiemetic medication does not address other cancer treatment side effects. Administered by a healthcare provider, the injection should be used as directed. Continue injections until your physician determines it's safe to discontinue; oral medication may then be prescribed. Common side effects, such as injection site discomfort, headache, bowel irregularities (constipation or diarrhea), and fatigue, generally resolve upon cessation of treatment. Persistent or bothersome symptoms should be discussed with your doctor, who can offer management strategies. Prior to use, disclose any pre-existing heart or liver conditions, or gastrointestinal obstructions, to your physician. Also inform them of all other medications, particularly those for epilepsy, cardiac issues, cancer, or depression, as interactions are possible. Pregnant or breastfeeding individuals should consult their healthcare team before using this medication.
Primary Ingredients of Graniarc 1mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Graniarc 1mg Injection
Chemotherapy-induced emesis
Major Benefits of Graniarc 1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Graniarc 1mg Injection:
- Injection site pain
- Constipation
- Diarrhea
- Headache
- Weakness
- Insomnia (difficulty in sleeping)
How to use Graniarc 1mg Injection:
The medication will be administered by your physician or their registered nurse; please refrain from self-medicating.
How Graniarc 1mg Injection works:
Graniarc 1mg injection is an anti-nausea medicine. Its mechanism of action involves the inhibition of serotonin, a neurotransmitter in the brain, which can trigger nausea and vomiting associated with cancer therapy or post-operative recovery.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Graniarc 1mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The use of Graniarc 1mg Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; clinical data in humans, however, remain scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Graniarc 1mg Injection while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Graniarc 1mg Injection.
KidneySAFE IF PRESCRIBED
Graniarc 1mg Injection appears safe for individuals with kidney impairment. Available evidence indicates dose modification may not be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Graniarc 1mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Graniarc 1mg Injection :
Should you forget a Graniarc 1mg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Graniarc 1mg Injection
| Label | Value |
|---|---|
| Chemical Type | Indazole-based compound |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Category | 5-HT3 receptor blockers |
